Michael Carter
General Counsel bei MVP Laboratories, Inc.
Profil
Michael Carter has been Director of Regulatory Affairs for MVP Laboratories, Inc. since 2008.
He joined MVP Laboratories in 2004 as a Consultant.
Prior to joining MVP Laboratories, he worked at Jensen-Salsbury Laboratories, Welcome Research Laboratories, Cooper Animal Health, Mallinckrodt Veterinary, Inc., and Schering-Plough Animal Health.
Dr. Carter received a BA degree in Biology from Texas Christian University in 1964, an MA degree in Biology from Texas Christian University in 1967, and a PhD in Virology and Epidemiology from Baylor College of Medicine in May 1972.
Aktive Positionen von Michael Carter
| Unternehmen | Position | Beginn |
|---|---|---|
MVP Laboratories, Inc.
 MVP Laboratories, Inc. Pharmaceuticals: MajorHealth Technology MVP Laboratories, Inc. manufactures veterinary vaccines. Its products include conventional vaccines, autogenous swine vaccines, autogenous bovine vaccine, autogenous specialty vaccines, adjuvants, and dietary supplements. The company was founded by Mary Lou Chapek, Lysle Wilkins, and F. W. Kullenberg in 1981 and is headquartered in Omaha, NE. | General Counsel | 01.01.2004 |
Ehemalige bekannte Positionen von Michael Carter
| Unternehmen | Position | Ende |
|---|---|---|
Schering-Plough Animal Health Corp.
 Schering-Plough Animal Health Corp. Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Schering-Plough Animal Health Corp. develops and manufactures pharmaceutical and biological products for food producing animals. The company is based in Union, NJ. | Corporate Officer/Principal | - |
Mallinckrodt Veterinary, Inc.
 Mallinckrodt Veterinary, Inc. BiotechnologyHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Veterinary, Inc. makes vaccines, growth agents, and parasite-killing products. Mallinckrodt Veterinary was acquired by Schering-Plough Corp., a SUB of Merck & Co., Inc. from Mallinckrodt, Inc.(Old) on July 01, 1997 for $405 million. | Corporate Officer/Principal | - |
Ausbildung von Michael Carter
| Texas Christian University | Undergraduate Degree |
| Baylor College of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Mallinckrodt Veterinary, Inc.
Mallinckrodt Veterinary, Inc. BiotechnologyHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Veterinary, Inc. makes vaccines, growth agents, and parasite-killing products. Mallinckrodt Veterinary was acquired by Schering-Plough Corp., a SUB of Merck & Co., Inc. from Mallinckrodt, Inc.(Old) on July 01, 1997 for $405 million. | Health Technology |
Schering-Plough Animal Health Corp.
Schering-Plough Animal Health Corp. Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Schering-Plough Animal Health Corp. develops and manufactures pharmaceutical and biological products for food producing animals. The company is based in Union, NJ. | Health Technology |
MVP Laboratories, Inc.
MVP Laboratories, Inc. Pharmaceuticals: MajorHealth Technology MVP Laboratories, Inc. manufactures veterinary vaccines. Its products include conventional vaccines, autogenous swine vaccines, autogenous bovine vaccine, autogenous specialty vaccines, adjuvants, and dietary supplements. The company was founded by Mary Lou Chapek, Lysle Wilkins, and F. W. Kullenberg in 1981 and is headquartered in Omaha, NE. | Health Technology |